Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00564_DB01076_nanopub.RASa7DTxS2OT8ts_n4p0kBE7ienz4ggspKLxTVUmdDLOE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00564_DB01076 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00564_DB01076 label "DDI between Carbamazepine and Atorvastatin - Carbamazepine, a p-glycoprotein inducer and strong CYP3A4 inducer, may decrease the effect of atorvastatin by increasing its efflux and metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if carbamazepine is initiated, discontinued or dose changed. [drugbank_resource:DB00564_DB01076]" assertion.
- drugbank_resource:DB00564_DB01076 identifier "drugbank_resource:DB00564_DB01076" assertion.
- drugbank_resource:DB00564_DB01076 title "DDI between Carbamazepine and Atorvastatin - Carbamazepine, a p-glycoprotein inducer and strong CYP3A4 inducer, may decrease the effect of atorvastatin by increasing its efflux and metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if carbamazepine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00564 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB01076 assertion.
- drugbank:DB01076 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB01076 assertion.